Santhera Pharmaceuticals Holding AG
F:S3F0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Santhera Pharmaceuticals Holding AG
F:S3F0
|
CH |
|
S
|
SciBase Holding AB (publ)
F:5J3
|
SE |
|
Sphere Entertainment Co
F:MQ2
|
US |
|
G
|
Graco Inc
F:GA8
|
US |
|
Enagas SA
MAD:ENG
|
ES |
|
U
|
Ultragenyx Pharmaceutical Inc
F:UP0
|
US |
|
T
|
Takara Bio Inc
F:TF2
|
JP |
|
H
|
Helium Evolution Inc
OTC:HEEVF
|
CA |
|
Athabasca Oil Corp
F:ATI
|
CA |
|
Housing Development and Infrastructure Ltd
BSE:532873
|
IN |
|
Jastrzebska Spolka Weglowa SA
F:J2S
|
PL |
Shareholder Yield
Current shareholder yield for S3F0 is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
S3F0 Price
Santhera Pharmaceuticals Holding AG
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -16% |
| Market Capitalization | 244.2m EUR |
| Shares Outstanding | 15 150 000 |
| Percentage of Shares Shorted |
N/A
|
